Boardroom Alpha
Boardroom Alpha
ADUS · Current Report (Form 8-K) · Filed August 4, 2025

Addus Homecare Corp — Current Report (Form 8-K)

Form
8-K
Filed
August 4, 2025
Period
Aug 4, 2025
Ticker
ADUS
Accession
0001437749-25-024617
Boardroom Alpha · Filing insights

Addus HomeCare reports Q2 2025 results in a press release. The release was issued August 4, 2025.

About Addus Homecare Corp
Market cap
$1.7B
1Y TSR
−16.8%
3Y TSR
+0.8%
Board grade
B+
Sector
Healthcare
CEO
R Dirk Allison
Last annual meeting: Jun 10, 2026 · View full Addus Homecare Corp profile →
adus20250801_8k.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): August 4, 2025
 
ADDUS HOMECARE CORPORATION
(Exact name of registrant as specified in its charter)
     
Delaware
001-34504
20-5340172
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 
6303 Cowboys Way, Suite 600
Frisco, Texas
 
75034
(Address of principal executive offices)
 
(Zip Code)
 
(469) 535-8200
(Registrants telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Common Stock, $0.001 par value per share
 
ADUS
 
The Nasdaq Stock Market, LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company. ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 2.02
Results of Operations and Financial Condition.
 
On August 4, 2025, Addus HomeCare Corporation (the “Company”) issued a press release (the “Press Release”) announcing, among other matters, the Company’s results of operations for the fiscal quarter ended June 30, 2025. A copy of the Press Release is furnished herewith as Exhibit 99.1 to this report and is incorporated herein by reference.
 
Item 7.01.
Regulation FD Disclosure
 
On August 4, 2025, the Company issued the Press Release, announcing, among other matters, its results of operations for the fiscal quarter ended June 30, 2025, the text of which is set forth as Exhibit 99.1.
 
Item 9.01
Financial Statements and Exhibits.
 
(d) Exhibits:
 
Exhibit
No.
Description
   
99.1
   
104
Cover Page Interactive Data File (embedded within Inline XBRL document).
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
ADDUS HOMECARE CORPORATION
Date: August 4, 2025
By:
/s/ Brian Poff
Brian Poff
Chief Financial Officer
 
 
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Addus Homecare Corp (ADUS)

Reference

Frequently asked questions

When did Addus Homecare Corp file this 8-K?
Addus Homecare Corp (ADUS) filed this Current Report (Form 8-K) with the SEC on August 4, 2025. The accession number assigned by EDGAR is 0001437749-25-024617.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Addus HomeCare reports Q2 2025 results in a press release. The release was issued August 4, 2025. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Addus Homecare Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Addus Homecare Corp has filed under CIK 1468328, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer